SOLICITATION NOTICE
A -- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
- Notice Date
- 7/7/2023 2:32:59 PM
- Notice Type
- Solicitation
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N95023R00037
- Response Due
- 8/4/2023 12:00:00 PM
- Archive Date
- 08/19/2023
- Point of Contact
- Michelle Cecilia, Phone: 3018277199, Valerie Whipple, Phone: 3018275218
- E-Mail Address
-
michelle.cecilia@nih.gov, valerie.whipple@nih.gov
(michelle.cecilia@nih.gov, valerie.whipple@nih.gov)
- Description
- The Therapeutic Development Branch (TDB) within the Division of Preclinical Innovation (DPI) at the National Center for Advancing Translational Sciences (NCATS) conducts translational research in the area of human therapeutics development. The scope of this contract is for Chemistry, Manufacturing, and Control (CMC) services for Drug Products. The objective of these support services is to ensure receipt of formulated Drug Product (DP) of sufficient quality and quantity to support preclinical, �IND-enabling and clinical studies.� The Contractor shall provide support for a broad range of preclinical services required for the design, development, manufacture, and release of DP, and release of DP as Clinical Trial Material (CTM), including precursors, preliminary states, Reference Standards (RS) and all required testing. Ancillary products (e.g., placebos, diluents, adjuvants, master cell banks, testing standards, reference materials) and other materials manufactured or purchased to support clinical trials or CMC activities may also be required. All activities preliminary to manufacturing in accordance with current Good Manufacturing Practice (cGMP) may be required (e.g., development or engineering lots, formulation studies), even without an associated cGMP manufacturing task. All activities required to maintain material in a usable state, including storage, shipping, testing (in process, release, stability, and quality actions), and preparation of documents to support regulatory submissions may also be required. Product formats may include small molecules, short oligomeric compounds, biological (large) molecules, quaternary molecular assemblies (homogenous or heterogenous), vectors for gene therapy, nanoparticles, and any �of the above modified genetically, biologically, or chemically. Novel formats �identified after this draft might also be needed. Formats could also include Devices or Combination Products. The breadth of this Statement of Work (SOW) includes capabilities to support a range of activities differing in size, complexity, and duration. All applicable attachments in connection with this solicitation are available for download.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/82d0ecc591d94aaea7725e0040355f48/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06740199-F 20230709/230707230040 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |